PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1650011-5	1991	The neutral endopeptidase inhibitor phosphoramidon (10(-5) M) potentiated the effect of VIP, so that the CBF dose-response curve for VIP was shifted to lower concentrations by 0.5 log U.	phosphoramidon	36-50	VIP peptides	Oryctolagus cuniculus	88-91	
1650011-5	1991	The neutral endopeptidase inhibitor phosphoramidon (10(-5) M) potentiated the effect of VIP, so that the CBF dose-response curve for VIP was shifted to lower concentrations by 0.5 log U.	phosphoramidon	36-50	VIP peptides	Oryctolagus cuniculus	133-136	
1650011-6	1991	The administration of VIP increased cyclic AMP levels in epithelial cells, an effect that was also potentiated by phosphoramidon.	phosphoramidon	114-128	VIP peptides	Oryctolagus cuniculus	22-25